Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3564)	4/25/2001 4:59:25 PM
From: Jibacoa	Read Replies (2) \| Respond to of 52153

Some of the Biotech double digit movers today: ABGX: Up 10.26%. Prudential's target now raised to 40. siliconinvestor.com BPUR: Up 16.49%. On April 24 South African authorities granted marketing clearance to the company's blood substitute, called Hemopure. siliconinvestor.com KDUS: Up 19.05% (Back to $1) No apparent news since its 4Q report on March 30. siliconinvestor.com GLIA: Up 18.57% in spite of 1stQ release and stating that it had no product revenues in the latest first quarter and that it is pursuing additional funding, as well as strategic partners for its pharmaceutical programs. siliconinvestor.com SNRS: Up 10.41%.It will release its first quarter 2001 results tomorrow and will conduct a conference call at 1:30 p.m.(PDT) when it will discuss its quarterly results and the (ASCRS) meeting which opens Friday in San Diego. siliconinvestor.com TTP: Up 10,56% It announced today that it has executed an agreement with Novartis for the development and commercialization of Zomaril(TM) in Japan. siliconinvestor.com I didn't see any double digits loss in Biotechs today.<g> SEPR braked its drop and was up 3.90% on volume of 4,939,800 siliconinvestor.com Bernard